✦ LIBER ✦
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study
✍ Scribed by Nicole Forestier; Dominique Larrey; Dominique Guyader; Patrick Marcellin; Régine Rouzier; Alain Patat; Patrick Smith; Williamson Bradford; Steven Porter; Lawrence Blatt; Scott D. Seiwert; Stefan Zeuzem
- Book ID
- 116652344
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 651 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.